These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36240685)

  • 21. The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis.
    Kanbay M; Copur S; Siriopol D; Yildiz AB; Berkkan M; Tuttle KR; Zoccali C
    Eur J Clin Invest; 2023 Jan; 53(1):e13878. PubMed ID: 36120818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis.
    Eckel N; Meidtner K; Kalle-Uhlmann T; Stefan N; Schulze MB
    Eur J Prev Cardiol; 2016 Jun; 23(9):956-66. PubMed ID: 26701871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolically healthy obese phenotype and risk of cardiovascular disease: Results from the China Health and Retirement Longitudinal Study.
    Li H; He D; Zheng D; Amsalu E; Wang A; Tao L; Guo J; Li X; Wang W; Guo X
    Arch Gerontol Geriatr; 2019; 82():1-7. PubMed ID: 30710843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New metabolic health definition might not be a reliable predictor for mortality in the nonobese Chinese population.
    Wang Z; He Y; Li L; Zhang M; Ruan H; Zhu Y; Wei X; Wei J; Chen X; He S
    BMC Public Health; 2022 Aug; 22(1):1629. PubMed ID: 36038857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Metabolically Healthy Obesity in Patients with Andrological Problems.
    Lotti F; Rastrelli G; Maseroli E; Cipriani S; Guaraldi F; Krausz C; Reisman Y; Sforza A; Maggi M; Corona G
    J Sex Med; 2019 Jun; 16(6):821-832. PubMed ID: 30962157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.
    Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C;
    Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study.
    Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F
    Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of metabolic heterogeneity of obesity with frailty progression: Results from two prospective cohorts.
    He D; Qiu Y; Yan M; Zhou T; Cheng Z; Li J; Wu Q; Liu Z; Zhu Y
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):632-641. PubMed ID: 36575595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Metabolically Unhealthy Phenotype Is Associated with ADIPOQ Genetic Variants and Lower Serum Adiponectin Levels.
    Torres-Castillo N; Campos-Perez W; Rodriguez-Echevarria R; Rodriguez-Reyes SC; Martinez-Lopez E
    Lifestyle Genom; 2020; 13(6):172-179. PubMed ID: 33137807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic Obesity Phenotypes and Thyroid Cancer Risk: A Cohort Study.
    Kwon H; Chang Y; Cho A; Ahn J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Shin H; Ryu S; Rhee EJ
    Thyroid; 2019 Mar; 29(3):349-358. PubMed ID: 30648486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.
    Kuang M; Lu S; Xie Q; Peng N; He S; Yu C; Qiu J; Sheng G; Zou Y
    BMC Gastroenterol; 2022 Jun; 22(1):311. PubMed ID: 35752753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis.
    Alizadeh S; Esmaeili H; Alizadeh M; Daneshzad E; Sharifi L; Radfar H; Radaei MK
    Arch Endocrinol Metab; 2019 Jul; 63(4):427-437. PubMed ID: 31365625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.
    Mirzababaei A; Djafarian K; Mozafari H; Shab-Bidar S
    Endocrine; 2019 Mar; 63(3):439-462. PubMed ID: 30671787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolically healthy obesity, vitamin D, and all-cause and cardiometabolic mortality risk in NHANES III.
    Al-Khalidi B; Kimball SM; Kuk JL; Ardern CI
    Clin Nutr; 2019 Apr; 38(2):820-828. PubMed ID: 29525513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolically healthy obesity and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a protocol for a systematic review and meta-analysis of prospective studies.
    Tian S; Liu Y; Feng A; Lou K; Dong H
    BMJ Open; 2019 Oct; 9(10):e032742. PubMed ID: 31662402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.
    Oh CM; Park JH; Chung HS; Yu JM; Chung W; Kang JG; Moon S
    Medicine (Baltimore); 2020 Sep; 99(38):e22036. PubMed ID: 32957321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Course of Metabolically Healthy Overweight/Obese Subjects and the Impact of Weight Change.
    Zheng R; Liu C; Wang C; Zhou B; Liu Y; Pan F; Zhang R; Zhu Y
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27428997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.
    Song Z; Gao M; Lv J; Yu C; Guo Y; Bian Z; Wei Y; Yang L; Du H; Chen Y; Zhang J; Yao J; Chen J; Chen Z; Huang T; Li L;
    Eur J Endocrinol; 2022 Jan; 186(2):233-244. PubMed ID: 34874895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16.
    Ichikawa T; Okada H; Hamaguchi M; Nishioka N; Tateyama Y; Shimamoto T; Kurogi K; Murata H; Ito M; Iwami T; Fukui M
    Obesity (Silver Spring); 2024 May; 32(5):999-1008. PubMed ID: 38444281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.